About Picker

Picker is an independent health and social care charity with expertise in understanding, measuring, and improving people’s experiences of care. We pioneered the patient experience approach, now widely adopted around the world, and advocate for the delivery of the ‘highest quality person centred care for all, always’ – centred around our eight principles of person centred care. 

We work with policy makers, providers, professionals, and patients and the public alike to influence, inspire, and empower person centred care. We are commissioned by the Care Quality Commission (CQC) and NHS England (NHSE) to design, deliver and analyse the NHS patient survey programme, the cancer patient experience surveys, the neonatal care experience survey, and the NHS staff survey. If you have any questions about this submission, please contact Olli Potter, Policy and Public Affairs Manager ([email protected]).


Consultation response

1. How should the national cancer strategy improve outcomes? 

Experience of care is one of the three domains of healthcare quality, alongside effectiveness and patient safety. The national cancer strategy should embed this tripartite definition of quality, in line with the recently published programme for government which commits to “improving outcomes through person centred care” and embedding “an outcomes-focused approach to health and care, using evidence, data and patient experience to shape, deliver and improve services”.

The plan commits to “more person-centred cancer care”, an ambition that we welcome and support. This must remain a core component of the national strategy matched by a focus to gathering and acting on patient experience insight at every stage of the cancer journey, from receiving a diagnosis and navigating treatment, to living with and beyond cancer.

Efforts to improve experience of care need to be grounded in a set of core principles. The Picker Principles of Person Centred Care outline the eight priorities that matter most to people accessing services and receiving care, including:

  • Fast access to reliable healthcare treatment
  • Effective treatment by trusted professionals
  • Continuity of care and smooth transitions
  • Involvement and support for family and carers
  • Clear information, communication and support for self-care
  • Involvement in decisions and respect for preferences
  • Emotional support, empathy and respect
  • Attention to physical and environmental needs.

As care rapidly becomes increasingly digitised, it is important that we also consider how digital tools are designed to be person centred – Picker’s Principles of Person Centred Digital Care outline that tools should be: inclusive, convenient and flexible, empowering, secure, and trusted and ethical.

Improving experience and outcomes requires accurate, robust measurement of patient insights accompanied by support for providers to value, explore and utilise experience data appropriately at all levels to drive transformation and change. For this reason, it is important that providers and their staff are supported to understand and act on the data they receive. 
 

They are opportunities for learnings from England to be applied in Wales and vice versa – for this reason we have included best practice examples from the annual Picker Experience Network (PEN) Awards from both Wales and England. We have also included data from the 2021 Wales Cancer Patient Experience Survey (WCPES) alongside the 2021 and 2025 National Cancer Patient Experience Surveys (NCPES) in England, which Picker is commissioned to deliver for NHS England.

 

2. How can more cancers be detected at earlier stages?

Other organisations are better placed to respond to this question, but we would advocate for clear communication to the public on what to look out for and where to turn when they have concerns, and this must be matched by improved access to care. It is particularly important to consider how to reach underserved communities and to consider non-traditional communications routes. This is particularly important with the increased use of Artificial Intelligence (AI) as a source of health information.

In our response to the Department of Health and Social Care’s (DHSC) 2025 consultation on the National Cancer Plan, we noted that respondents to the National Cancer Patient Experience Survey highlight access issues as an area of concern.

 

3. How should the NHS prepare to deliver future cancer treatments?

Other organisations are better placed to respond to this question, but we would advocate for patients and the public to be involved in the co-design of new services from the beginning. 

 

4. What support should individuals, carers and families receive during and after cancer treatment?

‘Involvement in decision making and respect for preferences’, and ‘Involvement and support for family members and carers’ are both core principles of person centred care. Data from the 2021 Wales Cancer Patient Experience Survey shows, however, that there is considerable room for improvement in the involvement of patients and carers during and after cancer treatment – for example, only 37% of respondents said the team delivering their care ‘completely’ discussed the impact of cancer on their daily life. Similarly, only 37% of respondents said that family or a friend ‘definitely’ had enough opportunities to speak to professionals, compared to 75% of respondents in England in 2021 who reported a family member or carer was able to be involved in decisions about their treatment and 55% who said that family or someone else close to them were given all the information they needed to help care for them at home. After leaving hospital, only 31% of respondents in Wales said that they were ‘definitely’ given enough care and help from their GP, compared to 44% in England (both in 2021).

In England, 72% of respondents in 2021 said they ‘definitely’ had a discussion with a member of the team looking after them about their needs or concerns, while 93% said that their care team helped them to create a care plan to address their needs. 99% said a member of the team reviewed the plan with them to make sure it continued to reflect their needs. By comparison, only 30% of respondents said they were offered a written care plan in the 2021 Wales Cancer Patient Experience Survey, and the survey does not contain further questions on care planning. 

In 2024, Aneurin Bevan University Hospital Board’s ‘Enhanced psychological wellbeing project’ was shortlisted for the ‘Cancer Experience of Care’ award at the Picker Experience Network (PEN) Awards (p.17). This project was initiated as a result of patient feedback and sought to improve emotional support for cancer patients. The programme trained staff and volunteers in areas including the impact of cancer on sex and intimacy, understanding the impact of cancer on LGBTQ+ patients and parents, and managing uncertainty. Patient workshops were also offered in living with uncertainty, mindfulness and managing fatigue. The project sought to drive system and culture change and to ensure consistency and awareness across teams to avoid unmet emotional need, while acknowledging that some patients require tailored support. The project saw an increase in both patient and staff satisfaction.

 

5. What opportunities exist to strengthen cancer research, clinical trials and innovation in Wales?

Data from the 2021 Wales Cancer Patient Experience Survey shows that only 20% of respondents reported being offered the opportunity to take part in cancer research. This is much lower than the 44% who reported opportunities to take part in research in England in the same year, which has since increased to 46% in 2025. In our response to the Department of Health and Social Care’s 2025 consultation on the National Cancer Plan, we noted that improvement in awareness of research opportunities has been relatively stagnant in recent years and that more needs to be done to improve access and knowledge of trial involvement opportunities. As part of a commitment to more person centred care, both in Wales and England, governments should explore national awareness raising campaigns in combination with provider engagement to create more opportunities for people to take part in research.

We contributed to research by The Institute of Cancer Research (ICR), published in December 2021, on the barriers to access to clinical trials. We found barriers at all stages of clinical trials, including at initiation and recruitment phases. The ICR recently published an update to this research in June 2026.
 

6. What future workforce, equipment and facilities will be needed to deliver high quality cancer care in Wales?

Other organisations are better placed to respond to elements of this question, however, ‘Attention to physical and environmental needs’ is one of our eight Principles of Person Centred Care, and it is important that patients, service users, their families and carers are involved in designing facilities that are person centred.

In 2025, Hywel Dda University Health Board’s Leri Cancer Unit was a runner up in the ‘Environment of Care’ category at the Picker Experience Network (PEN) Awards (p.96). This unit, primarily funded by charitable income, opened in May 2025 after careful and considered co production with patients, staff, artists and the local community. The artwork reflects Welsh culture and landscapes, creating a bilingual and bespoke healing environment to provide emotional and clinical support to the people it serves. Patients have reported improved satisfaction and better emotional comfort in the unit, while staff have reported improved morale, pride and motivation. This is just one example of how patients and local communities can be involved in ensuring facilities are person centred.

 

7. What improvements in digital systems and cancer data will support improved care and outcomes?

While Wales does have a Cancer Patient Experience Survey, it was last published in 2021 and in 2016 before that. This limits the usefulness of the data and insights and leaves a considerable gap in the knowledge of patient experience of cancer services since 2021, particularly in the period where services have been recovering post-pandemic. NHS England runs the National Cancer Patient Experience Survey (NCPES) and the Under 16 Cancer Patient Experience Survey (U16 CPES) annually, providing robust evidence and year-on-year data for comparison and tracking of data trends. Both surveys offer qualitative and quantitative insights into patient experiences of cancer services. Quantitative data can be presented at a national level, as well as cancer alliance, integrated care board, trust and site levels. 

The 2021 survey results show that in Wales the overall experience of cancer care was 8.67 compared to England’s 8.92. While these overall scores provide a useful comparison, exploring the data in greater detail can offer a richer understanding of people’s experiences and help identify opportunities for improvement. In England, interactive dashboards support this exploration by allowing staff, patients and the public to examine results across different population subgroups. Developing a similar resource in Wales could support greater transparency and access to survey findings. 

In our view, the Welsh government should explore recommissioning the Wales Cancer Patient Experience Survey, with a commitment to collecting feedback at regular intervals to support ongoing monitoring. Consideration should also be given to collecting data on the experience of under 16s in cancer services (with a consideration of small numbers reporting). Regular feedback should be seen as an important tool in providing more person centred care. 

In 2026, Bristol NHS Foundation Trust was shortlisted at the Picker Experience Network (PEN) Awards for its ‘Improving patient experience of cancer care’ project (p.54). This project designed a real time cancer experience survey to complement the National Cancer Patient Experience Survey. A digital dashboard was hosted in Microsoft Power BI to make the information accessible to clinical and operational staff and allows staff to respond quickly to concerns and recognise positive practice.

In 2025, Royal Devon University Healthcare NHS Foundation Trust won in the ‘Cancer experience of care’ category at the PEN Awards for their ‘Optimising cancer personalised care and support offers with digital solutions’ (p.158). This project delivered a more personalised End of Treatment Summary (EoTS) document by involving key stakeholders in its design. The revised document offered patients one source of truth, reduced completion time for staff, and helped identify cases of recurrence due to information and rapid re-access. The document supports self-management, supporting patient empowerment.

 

8. What actions will help address differences in outcomes between people with protected characteristics, people living in different health board areas, or people affected by different types of cancer?

Data from the 2021 Wales Cancer Patient Experience Survey show that men have better experiences of cancer care than women and that experiences differ by ethnicity, age, cancer type and deprivation levels. As above in our response to Question 7, more regular reporting of patient experience insights in Wales would support the tracking of health inequalities and help identify where more targeted support is required. NHS England has recently published separate analysis on the National Cancer Patient Experience Survey 2025, with a lens on inequalities. It identified younger patients, several ethnic minority groups, LGBTQ+, people with multiple long term conditions and certain tumour pathways as reporting poorer experiences of care. 

Below are a number of examples of best practice from the Picker Experience Network (PEN) Awards that demonstrate examples of innovating to support underserved communities. In 2025, West Yorkshire and Harrogate Cancer Alliance was shortlisted for their ‘Dementia and Cancer Together Project’ (p.212). This project was in response to the fact that Harrogate district has a higher than national average population over 65 and a significant number of people living with dementia and cancer. The Alliance collaborated with Dementia Forward to enhance knowledge and collaboration between clinical staff and the Dementia Forward team to improve patient care and experience. 

Also in 2025, Northumbria Healthcare NHS Foundation Trust was a runner up for their ‘Innovating the traditional lung cancer patient pathway’ project (p.132). This project set up the first lung oncology virtual ward, ensuring timely access for acute symptom management and deterioration. Feedback from patients and staff has been positive. 

In 2024, West Yorkshire and Harrogate Cancer Alliance won at the PEN Awards for their ‘Remove the doubt’ project in the ‘Cancer experience of care’ category (p.112). This project was a collaboration with the charity, OUTPatients, and marketing agency, Mobas, to raise awareness of the signs and symptoms of cervical cancer and to increase screening uptake in the LGBTQ+ community. While national screening rates have declined, screening uptake in Calderdale increased by 1%, and up to 2.6% at certain practices. 

In the same year, South Tyneside and Sunderland NHS Foundation Trust was a runner up for their ‘Personalised cancer care’ project (p.93). This initiative developed a digital personalised assessment and support plan, and a unique digital referral function, as well as a personalised care data dashboard. For patients, a cancer information hub was created, offering support through films and podcasts developed with local professionals and patients.

These examples all demonstrate how co-produce initiatives can provide tailored support to communities at risk of and experiencing health inequalities.

 

9. How can success in improving cancer services and outcomes be measured?

As in our responses to previous questions, a priority for the national cancer strategy must be asking patients about their experience and then using this data to drive improvement. Providers and staff must be equipped to act on the data they receive as part of these plans. Patient reported experience measures are just one part of evaluation and transformation, and there is an importance to ensuring comprehensive outcome and audit data as well. 

 

10. Are there any other comments or suggestions you would like to make?

No response.